Immunogenicity was assessed by hemagglutination-inhibition (HI) prevaccination and 28 days after each vaccination. Immunogenic non-inferiority QIV versus TIV for shared strains, and superiority ...

The bivalent respiratory syncytial virus prefusion F vaccine is highly effective and well tolerated against RSV-associated ...

Sanofi SNY announced that the FDA has granted a fast-track designation to its mRNA vaccine candidate for the prevention of ...

However, their clinical application is limited by an incomplete understanding of their immunogenicity. Now, researchers from Juntendo University developed a humanized mice model and elucidated the ...

As part of the Fast Track designation, Sanofi is set to launch a Phase I/II trial to evaluate the immunogenicity and safety of its novel mRNA vaccine in preventing chlamydia.

Chlamydia vaccine candidate granted fast track designation by the US FDAChlamydia infection can contribute to pelvic inflammatory diseases in ...

The approval was based on a comprehensive clinical data package, which included a single phase 1 trial and a phase 3 trial.

The FDA acknowledges the necessity of immunogenicity assays to assess immune responses to components of oligonucleotide therapeutics, particularly those with carriers or conjugates.

Imunon has reported new immunogenicity and safety data from its proof-of-concept Phase I trial’s ongoing analyses of the IMNN-101 DNA plasmid vaccine. The investigational vaccine, based on the ...

Presentation Details Title: Safety and Immunogenicity of PIV5-Vectored RSV Intranasal Vaccine (BLB201) in Healthy Adults and Children Date/Time: March 13, 2025 / 8:30 am to 8:45 am (GMT-3 ...